AzTrials
AzTrials

Intensive Care (ICU) MyopathyNCT01364714

Biomechanical Properties in Intensive Care Unit (ICU) Survivors 12-month After Discharge

An observational study of Intensive Care (ICU) Myopathy, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Intensive care unit (ICU) admission is associated with muscle weakness and ICU survivors report persevering limitation of physical capacity for years after discharge. Limited information is available about the underlying biomechanical properties responsible for this muscle function impairment. Read more about this study

Who is it for?
Ages 50 to 75 years, men onlyHealthy volunteers can take part
Conditions the study is for
Intensive Care (ICU) Myopathy
How many people
32 participants
Where
1 siteDenmark
Study dates
Jan 2010to Mar 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • Men only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: ICU survivors 12 months after discharge compared to age and gender matched controls

Who may be able to join

  • ICU length of stay > 72 hours
  • Informed consent

Who cannot join

  • BMI>30
  • Neuromuscular or psychiatric disease

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Biomechanics and Motor Control Laboratory, Department of Exercise and Sport Sciences, University of Copenhagen

    Copenhagen, DK-2100 OE

Other trials in Denmark

About this study

Official title: Biomechanical Properties in ICU Survivors 12-month After Discharge

Intensive care unit (ICU) admission is associated with muscle weakness and ICU survivors report persevering limitation of physical capacity for years after discharge. Limited information is available about the underlying biomechanical properties responsible for this muscle function impairment.

Keywords
ICU acquired weakness
Medical subject headings
Muscular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01364714
Study groupRoleWhat they receive
ICU survivorsMale ICU survivors 12 month after discharge
ControlsAge and gender matched controls

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jun 2011 (estimated)
  2. Study startJan 2010
  3. Primary completionFeb 2011
  4. Study completionMar 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01364714
Sponsor's protocol ID
2008-120-25298
Status last verified
Sep 2017
First submitted
31 May 2011
Last updated
29 Sep 2017
Results posted
No

Questions about this trial

What is this clinical trial studying?

An observational study of Intensive Care (ICU) Myopathy, run by Copenhagen University Hospital, Rigshospitalet at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in